Journal of Clinical Oncology - ASCO Publications
WEBSep 9, 2024 · A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a …
ASCO Clinical Practice Guidelines | Journal of Clinical Oncology
WEBFor more information on these guidelines, including information about planned guidelines, please access the ASCO.org guidelines page. Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical ...
Management of Immune-Related Adverse Events in Patients …
WEBPURPOSE To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy. METHODS A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine, nursing ...
Management of Cancer Therapy–Associated Oral Mucositis
WEBFeb 3, 2020 · Abstract. Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. Even seemingly uncomplicated mucositis, which is often self-limited, can result in intense patient discomfort and decline in quality of life. Severe mucositis …
Management of Stage III Non–Small-Cell Lung Cancer: ASCO …
WEBDec 22, 2021 · PURPOSE To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary oncology, community oncology, research methodology, and advocacy experts was convened to conduct a literature search, which included systematic ...
Prevention and Management of Chemotherapy-Induced …
WEBJul 14, 2020 · PURPOSE To update the ASCO guideline on the recommended prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors. METHODS An Expert Panel conducted targeted systematic literature reviews to identify new studies. RESULTS The search strategy identified 257 new references, which led to a full-text review of 87 manuscripts ...
ASCO Annual Meeting | ASCO Daily News
WEBJune 19, 2024. Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the NADINA trial, as well as other new treatment options for patients with advanced cancers. Breast Cancer.
Recent Advances in the Management of Metastatic Prostate Cancer
WEBIn 2021, it is estimated that 26% of new noncutaneous cancer cases will be because of prostate cancer resulting in 11% of cancer-related deaths in the United States, making it the most common malignancy in men and the second leading cause of cancer mortality. 1 Following onset of metastatic disease, the disease is invariably fatal with a 5-year survival rate of only 30%.
Management of Cancer Cachexia: ASCO Guideline
WEBPURPOSE To provide evidence-based guidance on the clinical management of cancer cachexia in adult patients with advanced cancer. METHODS A systematic review of the literature collected evidence regarding nutritional, pharmacologic, and other interventions, such as exercise, for cancer cachexia. PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and systematic ...
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on ...
WEBJan 14, 2021 · Although the diagnostic criteria of malnutrition may differ depending on the tool that is used, the prevalence of malnutrition was reported in several surveys as being up to 50% among hospitalized patients with cancer. 3,8-11 Furthermore, the severity of weight loss is an independent predictive factor for shorter overall survival 5; about 10%-20% of all cancer mortality is directly related to ...
Skip to content